Although the markets of emerging economies are not as developed as those of developed nations’, they are now considered the main drivers of global growth. In fact, recent reports claim that 70% of global growth in the coming four years will be driven by emerging markets. Of that growth, about 40% should be contributed by […]

Read More →

The FX and CFD market is extremely competitive, with hundreds of brokers offering virtually similar services. So, when virtual currencies like bitcoin, ethereum, litecoin and others became popular, some brokers began to offer their trade. Now, there are a number of such FX and CFD brokers who offer cryptocurrency trading in addition to their usual […]

Read More →

The Mexican peso has been a proxy currency for other developing and emerging economies in the world. Changes in the value of the peso have always reflected more than just Mexico’s economy, and that gave it the proxy status. Besides that, it has a lot of liquidity while still avoiding any capital controls, which investors […]

Read More →

Aegean Marine Petroleum Network Inc. (NYSE:ANW) announced financial and operating results for the third quarter ended September 30, 2016. Nikolas Tavlarios, Aegeans President, commented, We delivered another quarter of solid results against a backdrop of slowness in the container segment and volatile commodity markets. Despite these headwinds, we continue to achieve profitability and strong volumes […]

Read More →

Analog Devices, Inc. (NASDAQ:ADI) announced the acquisition of SNAP Sensor SA, a privately held company based in Switzerland that specializes in highly innovative vision sensing technologies. The acquisition will advance Analog Devices’ leadership position in sensing and signal processing and build upon platform-level Internet of Things (IoT) solutions such as ADI’s award-winning Blackfin Low Power […]

Read More →

Celator Pharmaceuticals Inc. (NASDAQ:CPXX) announced positive results from the Phase 3 trial of VYXEOS™ (cytarabine:daunorubicin) Liposome for Injection (also known as CPX-351) in patients with high-risk (secondary) acute myeloid leukemia (AML) compared to the standard of care regimen of cytarabine and daunorubicin known as 7+3. The trial met its primary endpoint demonstrating a statistically significant […]

Read More →

Brazil is South America’s largest country, but it has been one of the worst-performing economies in the region of late. Now, the current president is hoping he can turn this around and return Brazil back to its former glory through reform. Past performance of the Brazilian economy The Brazilian economy has been spiraling downwards for […]

Read More →